Biofrontera Inc. (BFRI)
NASDAQ · Healthcare
Biofrontera Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Biofrontera Inc. shareholder equity for the quarter ending December 31, 2025 were 10.5M, a 136.41% increase year-over-year.
- Biofrontera Inc. shareholder equity for 2025 were 10.5M, a 136.41% increase from 2024.
- Biofrontera Inc. shareholder equity for 2024 were 4.4M, a 7.51% decrease from 2023.
- Biofrontera Inc. shareholder equity for 2023 were 4.8M, a 79.93% decrease from 2022.
- Biofrontera Inc. shareholder equity for 2022 were 23.9M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Biofrontera Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $10 |
| 2024 | $4 |
| 2023 | $5 |
| 2022 | $24 |
| 2021 | $11 |
| 2020 | $6 |
| Biofrontera Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $10 |
| 2024-12-31 | $4 |
| 2023-12-31 | $5 |
| 2022-12-31 | $24 |
| 2021-12-31 | $11 |
| 2020-12-31 | $6 |
Biofrontera Inc. Shareholder Equity — FAQ
Biofrontera Inc. (BFRI) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BFRI's shareholder equity history?
The chart and table above show Biofrontera Inc.'s shareholder equity by year and by quarter, including the growth rate.